A new cannabis product is set to offer adult-use consumers in Ontario an option to navigate the upcoming rush of brands available upon legalization.

Named the “Discovery Series Vol. 1,” this is the first iteration of the Cannabis Collections AHLOT, which will be sold starting on October 17.


The package will offer consumers five 1-gram strains from five Canadian licensed producers (LP). Four of these products are tied to public cannabis ventures.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Here’s a breakdown of the producers selected, the respective public plays for investors, the brands each represent and the product offered in the collection:

Organigram (TSXV:OGI) | Edison Cannabis | Rio Bravo (Wabanaki) | Sativa
Emblem (TSXV:EMC)| Symbl | Solar Power (Sour Kush) | Hybrid
Solace Health – TerrAscend (CSE:TER) | Haven St. | No. 405 (Blueberry Kush) | Indica
7ACRES – Supreme Cannabis Company (TSXV:FIRE) | 7ACRES | Sensi Star | Indica

Starseed Holdings | Saturday | Saturday Afternoon (CBD MediHaze) | CBD Dominant Sativa

Final design of the AHLOT Cannabis Collections: Discovery Series Vol. 1 SUBMISSION

Based on final design for the product, Greg Pantelic, CEO of AHLOT, told the Investing News Network (INN) AHLOT took cues from a novelty item in the beer industry.

According to Pantelic, after conducting some research with breweries, an overwhelming majority of consumers that try a flight of beer — which is a serving of different types of beer in small glasses — end up ordering a separate pint afterwards.

The executive hopes this collection of cannabis products will act similarly and offer consumers a jumping off point for what he described as a “tsunami” of options come legalization.

“Frankly, the experience will be quite poor of a customer experience for anyone purchasing cannabis in the new legal environment,” Pantelic said. “It’s going to be like throwing darts.”

With the Canadian market on its way towards legalization, brands awareness has developed as a key element for investors to recognize and compare among companies in the public market.

“Not only will it be difficult to distinguish between the hundreds of new brands on the market, but it will be immensely daunting for consumers of all experience levels to determine which strains are right for them,” the executive said.

AHLOT will attempt to expand the line of collections and search for new brands to add into later volumes.

Ray Gracewood, Organigram’s chief commercial officer, said this variety pack is an extension of the consumption and buying patterns noticed by the company for “cannabis enthusiasts.”

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Entry of cannabis collection into Ontario market

AHLOT, which stands for A Higher Level Of Thought, holds a partnership with TerrAscend through an investment of C$2.5 million worth of convertible notes made by the CSE-listed company.

As part of TerrAscend’s supply agreement with the Ontario Cannabis Retail Corporation (OCRC), the AHLOT Cannabis Collections Discovery Pack will become available to consumers through online sales.

“Solace Health will provide fulfillment and distribution services of AHLOT branded products for Ontario consumers,” the company indicated in an announcement.

Robyn Rabinovich, TerrAscend’s VP of business development, said the company made this investment as a belief of the options for the cannabis space beyond cultivation businesses.

Pantelic told INN the company “made it very compelling from an economics perspective” for these producers to be involved in the product. It was only last week when all five producers discovered who else was part of the collection, according to the executive.

Pantelic said Solace Health, the subsidiary of TerrAscend, is licensed to purchase wholesale cannabis from different licensed producers and sell cannabis in Canada’s provinces, which includes AHLOT’s collections.

Investor takeaway

Organigram currently holds a “Strong Buy” rating on the analyst review aggregator site TipRanks, based on three separate recommendations.

A few of the public producers involved with the collection took hits in their shareprice on Wednesday following the announcement from AHLOT.

Organigram and Supreme both dipped 0.13 and 1.33 percent by the end of the trading session. On the other hand TerrAscend and Emblem rose 1.36 percent and 11.30 percent respectively.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Emblem and Supreme Cannabis Company are clients of the Investing News Network. This article is not paid-for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Appointment of Dr. Kelmendi, Assistant Professor of Psychiatry at Yale University and co-founder of the Yale Psychedelic Science Group, brings another experienced medical professional to Lobe’s advisory team.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Benjamin Kelmendi, MD, Assistant Professor of Psychiatry at Yale University School of Medicine, to its Scientific Advisory Board.

Keep reading... Show less

Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or ” Ayurcann “), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to unveil further details of its Phase 2 expansion plans.

Ayurcann has commenced trading on the Canadian Securities Exchange (” CSE “) on April 8, 2021 and subsequently announced a private placement of up to $500,000 (” Financing “), as per the Company’s press release dated April 12, 2021. The proceeds of the Financing are intended to be used to further pursue Phase 2 of the expansion of the production capacity of the Company’s Pickering facility.

Keep reading... Show less

New findings suggest the COVID-19 pandemic, combined with expanded state legalization, has attracted new consumers to the category and accelerated cannabis acceptance and adoption.

  • YouGov study indicates the number of current cannabis consumers has increased 56% within just two years compared to the 16% of Americans who reported current consumption in 2018.
  • 23% of current consumers say they tried cannabis for the first time within the past year.
  • More than half of cannabis consumers say they will purchase or try a new product or format this 420, indicating that the holiday is becoming increasingly focused on exploration and trial.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, released the results of a survey today showing one in four Americans currently consume cannabis, reporting they’ve tried some form of cannabis within the past twelve months. That’s a significant increase since 2018* when just 16% of U.S. adults reported current consumption, representing a 56% increase in just two years. What’s more, 23% of current cannabis consumers say they tried cannabis for the first time over the past year, suggesting the COVID-19 pandemic, combined with expanded state legalization, has rapidly accelerated cannabis acceptance and adoption in America.

Keep reading... Show less

Acquires Three Operating Dispensaries in Northeast Pennsylvania

Purchase price represents a mid-single digit multiple of KCR’s expected 2021 EBITDA

Keep reading... Show less